Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Treatment of Diarrhea with a Negative GI Panel

Initial Assessment and Management

  • The American Society of Clinical Oncology recommends evaluating the severity of diarrhea by assessing number of stools, stool composition, and signs of dehydration or systemic illness 3, 4
  • Dietary modifications should be implemented by eliminating lactose-containing products, alcohol, and high-osmolar supplements, as suggested by the Journal of Clinical Oncology [5, 6 is ignored in favor of 5]
  • Patients should be encouraged to consume 8-10 large glasses of clear liquids daily to prevent dehydration, according to the Journal of Clinical Oncology 5, 3
  • The BRAT diet, consisting of low-residue foods such as bananas, rice, applesauce, and toast, is recommended for patients with diarrhea, as suggested by the Journal of Clinical Oncology 5, 3

Hydration Therapy

  • The Infectious Diseases Society of America recommends using reduced osmolarity oral rehydration solution as first-line therapy for mild to moderate dehydration 1, 2
  • For severe dehydration, shock, altered mental status, or ileus, isotonic intravenous fluids such as lactated Ringer's or normal saline should be administered, according to the Infectious Diseases Society of America 1
  • Intravenous rehydration should be continued until pulse, perfusion, and mental status normalize in severe cases, as recommended by the Infectious Diseases Society of America 1
  • Once rehydrated, ongoing losses should be replaced with oral rehydration solution until diarrhea resolves, according to the Infectious Diseases Society of America 1

Pharmacological Management

  • The Infectious Diseases Society of America recommends that loperamide may be given to immunocompetent adults with acute watery diarrhea 1, 2
  • For persistent diarrhea despite loperamide treatment in adults, the National Comprehensive Cancer Network suggests considering increasing the loperamide dose or adding anticholinergic agents such as hyoscyamine or atropine 7
  • For severe or refractory diarrhea, octreotide may be considered, as suggested by the Journal of Clinical Oncology 5, 3

Special Considerations

  • The Journal of Clinical Oncology recommends following specific grading criteria and management protocols for cancer patients with treatment-induced diarrhea and negative GI panel 4
  • The Infectious Diseases Society of America suggests avoiding empiric antimicrobial therapy in patients with persistent watery diarrhea lasting 14 days or more 2
  • Probiotics may be offered to reduce symptom severity and duration in immunocompetent adults and children, according to the Infectious Diseases Society of America 1

Important Precautions

  • The Infectious Diseases Society of America recommends avoiding antimotility drugs in suspected or proven cases where toxic megacolon may result in inflammatory diarrhea or diarrhea with fever 1
  • Patients should be monitored for signs of dehydration or electrolyte imbalances, which require prompt intervention, as suggested by the Journal of Clinical Oncology 5, 3
  • Hospitalization should be considered for patients with severe dehydration, persistent grade 3-4 diarrhea, or those with complicating factors like immunosuppression, according to the Journal of Clinical Oncology 5, 3